TRT vs. steroid cycle bloodwork: what monitoring actually requires

What did @wiedzalab actually say?

Honestly, not much that's checkable. The transcript we have is a motivational phrase: "A king never waits. A king never bends. A king never relies on others. A king... NEVER GIS UP!" That's it. The caption, though, tells a different story. It outlines a genuinely interesting claim: that bloodwork panels should differ depending on whether someone is natural, on TRT, or running a performance-enhancing cycle. The caption specifically notes that for natural individuals, labs serve diagnostic purposes; for TRT patients, the goal is health monitoring; and for cycle users, additional risks come into play. We're fact-checking the caption's claims, because the spoken content gives us nothing clinical to work with.

Does the science back this up?

Yes, the caption's framework is directionally correct, and this isn't controversial among endocrinologists. The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism explicitly distinguish diagnostic testing from ongoing monitoring. For untreated, symptomatic men, you're looking at total testosterone, LH, FSH, and prolactin to find a cause. For men on TRT, the monitoring targets shift: hematocrit, PSA, lipids, and testosterone trough levels matter more than LH, which will be suppressed anyway by exogenous testosterone. Bhasin et al. (2018, Journal of Clinical Endocrinology and Metabolism) lay this out clearly. The idea that supraphysiologic androgen use, meaning cycling, requires additional monitoring, is also well-supported. Liver enzymes, lipid panels including HDL, and cardiac markers become more pressing when doses exceed therapeutic ranges, as documented by Rahnema et al. (2014, Fertility and Sterility).

What did they get wrong (or right)?

They got the general structure right. Separating bloodwork rationale by context is genuinely useful health communication, and most TRT content on TikTok does not bother making this distinction. Credit where it's due.

The problems are in what's missing. The caption stops mid-sentence: "Na cyklu dochodzi częstsz" meaning "On a cycle, there's more frequent..." and then cuts off. We don't know what frequency they're recommending or whether it's evidence-based. That's a significant gap. Recommending monitoring intervals is where the real clinical risk lives. Too infrequent and you miss rising hematocrit, which is associated with thrombotic events per Guo et al. (2014, PLOS ONE). The video also makes no distinction between oral and injectable androgens, which matters because 17-alpha-alkylated orals carry hepatotoxic risk that injectables typically don't, per Shahidi (2001, European Journal of Endocrinology). Without that nuance, the advice is incomplete at best.

What should you actually know?

If you're on TRT prescribed by a licensed provider, your monitoring panel should typically include total and free testosterone, hematocrit, hemoglobin, PSA if you're over 40, and a lipid panel. The Endocrine Society recommends checking hematocrit at three to six months and then annually once stable. This isn't optional, it's how providers catch polycythemia before it becomes a clot.

For people using androgens outside of a clinical setting at supraphysiologic doses, the risk profile is meaningfully different. HDL suppression can be dramatic. Khera et al. (2014, Journal of Sexual Medicine) found significant cardiovascular marker changes even at doses used by recreational bodybuilders. Cardiac imaging studies, including Baggish et al. (2017, Circulation), found structural heart changes in long-term anabolic steroid users. The caption is right that cycle users need more testing. But more testing doesn't make cycling safe, and no bloodwork panel eliminates cardiovascular or hepatic risk from supraphysiologic androgen exposure.

The motivational framing in the actual spoken content, kings and never giving up, is irrelevant to hormone health and worth noting for what it signals about audience targeting. That kind of language is common in spaces that romanticize performance-enhancing drug use.

Bottom line

The caption's three-way framework is legitimate and useful. The execution leaves out enough that it shouldn't be anyone's sole guide to bloodwork. Talk to a provider who specializes in men's health or endocrinology, not a TikTok caption that ends mid-sentence.